Stuttgart, Germany

Meike Hutt

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Schomdorf, DE (2019)
  • Stuttgart, DE (2019 - 2024)
  • Tuebingen, DE (2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Meike Hutt: A Pioneering Innovator in Cancer Immunotherapy

Introduction

Meike Hutt, based in Stuttgart, Germany, is a distinguished inventor known for her significant contributions to the field of cancer immunotherapy. With an impressive portfolio of nine patents, she has dedicated her career to developing innovative solutions that target cancer cells, enhancing diagnostic and therapeutic methods.

Latest Patents

Hutt's latest patents include groundbreaking discoveries in antigen binding proteins that specifically target melanoma-associated antigen A (MAGE-A) protein-derived antigens. These antigen binding proteins are designed to bind to the MAGE-A antigenic peptide in complex with major histocompatibility (MHC) proteins. This innovation holds promise for diagnosing, treating, and preventing cancerous diseases that express MAGE-A.

Additionally, she has developed engineered T cell receptors (TCRs) that recognize COL6A3 antigens. These novel TCR-based constructs aim to provide selective and specific targeting of tumors expressing COL6A3, offering new avenues for diagnosis, treatment, and prevention of related cancerous diseases.

Career Highlights

Meike Hutt has had a notable career, working with prominent organizations such as Immatics Biotechnologies GmbH and Universität Stuttgart. Her work has not only advanced the understanding and treatment of cancer but has also contributed to the development of innovative therapies that harness the power of the immune system.

Collaborations

Throughout her career, Hutt has collaborated with esteemed colleagues, including Felix Unverdorben and Sebastian Bunk. These partnerships have facilitated the exchange of ideas and fostered advancements in cancer immunology, further enhancing the impact of her inventions.

Conclusion

Meike Hutt stands out as a pioneering figure in the field of cancer immunotherapy. Her innovative patents reflect her commitment to combating cancer and improving patient outcomes. Through her ongoing research and collaborations, Hutt continues to pave the way for groundbreaking advancements in medical technology and therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…